Form 4 for IDXX Idexx Laboratories
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-14 · accession 0000874716-25-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-18 | 2025-02-14 | IDXX | MCKEON BRIAN P | EVP, CFO, Treas | M - OptEx | $0.00 | +1,162 | 31.2K | +4% | $0 |
| D | 2025-02-18 | 2025-02-14 | IDXX | MCKEON BRIAN P | EVP, CFO, Treas | F - Tax | $444.53 | -569 | 31.5K | -2% | -$252.9K |
| DM | 2025-02-18 | 2025-02-14 | IDXX | MCKEON BRIAN P | EVP, CFO, Treas | M - OptEx | $0.00 | -1,162 | 615 | -65% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-14 | M | A | 299 | $0.00 | 32,118.59 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-14 | M | A | 308 | $0.00 | 31,819.59 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-14 | M | A | 303 | $0.00 | 31,511.59 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-14 | M | A | 252 | $0.00 | 31,208.59 | D | — | — | (F1) Includes a total of 25 shares purchased under the Issuer's Employee Stock Purchase Plan on September 30, 2024 and December 31, 2024. |
| 5 | Common | Common Stock | 2025-02-14 | F | D | 569 | $444.53 | 31,549.59 | D | — | — | |
| 6 | Derivative | Restricted Stock Unit | 2025-02-14 | M | D | 299 | $0.00 | 894 | D | — · — to — | 299 Common Stock | (F5) Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning on February 14, 2025. |
| 7 | Derivative | Restricted Stock Unit | 2025-02-14 | M | D | 252 | $0.00 | 0 | D | — · — to — | 252 Common Stock | (F2) Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2022. |
| 8 | Derivative | Restricted Stock Unit | 2025-02-14 | M | D | 303 | $0.00 | 303 | D | — · — to — | 303 Common Stock | (F3) Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2023. |
| 9 | Derivative | Restricted Stock Unit | 2025-02-14 | M | D | 308 | $0.00 | 615 | D | — · — to — | 308 Common Stock | (F4) Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2024. |